EXTRACELLULAR MATRIX INTERACTIONS IN CARDIAC MORPHOGENESIS
心脏形态发生中的细胞外基质相互作用
基本信息
- 批准号:6242045
- 负责人:
- 金额:$ 16.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-01-01 至 1997-12-31
- 项目状态:已结题
- 来源:
- 关键词:animal genetic material tag blocking antibody cardiovascular disorder epidemiology cell cell interaction cell differentiation cell migration chick embryo collagen congenital heart disorder early embryonic stage elastin extracellular matrix fibronectins heart cell heart function heart valves histogenesis homeobox genes hyaluronate immunocytochemistry in situ hybridization laboratory mouse laboratory rat laminin molecular genetics myosins tissue /cell culture
项目摘要
A large proportion of congenital heart defects are seen in the valves and
membranous septa of the heart, which are in part derived from the
endocardial cushions. The morphogenesis of the endocardial cushions is a
complex process, involving a sequence of basic developmental events. These
include cell migration, proliferation, and differentiation. It is the goal
of this project to define this developmental sequence in greater detail
and to understand the role of specific genes in the process. The major
focus is on components of the extracellular matrix. The following
questions will be addressed. l) What is the role of the homeobox gene, Hox
7, in the initiation of cushion morphogenesis? This will be addressed by
examining the effects of anti-sense deoxyoligonucleotides on cushion
morphogenesis and on the expression of extracellular matrix components in
heart explant cultures and in ovo. 2) What extracellular matrix molecules
are expressed during cushion formation? This will be addressed by
immunohistochemistry with a battery of antibodies available in the
laboratory and by in situ hybridization in some cases of special interest.
3) What is the developmental effect of blocking the expression of specific
extracellular matrix components on cushion morphogenesis? This will be
carried out with blocking antibodies, where available, or anti-sense
deoxyoligonucleotides. In particular we will focus on hyaluronan and its
binding proteins (CD-44 and PG-M), collagen II, and a component of the
cardiac jelly (1E12) which has been identified recently in this
laboratory. 4) The role of other genes in cushion morphogenesis will be
studied subsequently, as they become characterized. 5) What is the
contribution of the cushion cells to the tissues and extracellular matrix
of the mature valves and septa of the heart? This question will be
addressed by immunohistological analysis after in situ labeling of cushion
cells with replication-defective, lac-Z labeled retrovirus, followed by
the reincubation of the windowed, injected chicken eggs.
很大一部分先天性心脏病是在瓣膜和
心脏的膜性隔膜,部分来源于
室内软垫内膜垫的形态发生是
一个复杂的过程,涉及一系列基本的发展事件。这些
包括细胞迁移、增殖和分化。这是目标
以更详细地定义该开发序列
并了解特定基因在这一过程中的作用。主要
重点是细胞外基质的成分。以下
问题将得到解决。l)同源框基因Hox的作用是什么
7、在垫状形态发生的起始阶段?这将通过以下方式解决:
检测反义脱氧寡核苷酸对缓冲垫的影响
形态发生和细胞外基质成分的表达,
心脏外植培养和卵内培养。2)什么细胞外基质分子
是在缓冲层形成时表达的吗这将通过以下方式解决:
免疫组化与一组抗体可在
实验室和原位杂交在一些特别感兴趣的情况下。
3)阻断特定的基因表达对发育有什么影响
细胞外基质成分对垫形态发生的影响?这将是
用封闭抗体(如可用)或反义
脱氧寡核苷酸特别是,我们将重点关注透明质酸及其
结合蛋白(CD-44和PG-M)、胶原II和胶原蛋白的组分。
心脏胶质(1 E12),最近在本研究中发现,
实验室4)其他基因在垫状形态发生中的作用将是
随后,随着它们的特征化,研究它们。5)是什么
垫细胞对组织和细胞外基质的贡献
成熟的瓣膜和隔膜该问题将被
通过原位标记垫后的免疫组织学分析来解决
细胞与复制缺陷,lac-Z标记的逆转录病毒,然后
重新孵育开窗注射的鸡蛋。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL SOLURSH其他文献
MICHAEL SOLURSH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL SOLURSH', 18)}}的其他基金
EXTRACELLULAR MATRIX INTERACTIONS IN CARDIAC MORPHOGENESIS
心脏形态发生中的细胞外基质相互作用
- 批准号:
6109979 - 财政年份:1998
- 资助金额:
$ 16.91万 - 项目类别:
CELL--ECM INTERACTIONS IN MYOCARDIAL FORM AND FUNCTION
心肌形态和功能中的细胞-ECM 相互作用
- 批准号:
3362274 - 财政年份:1989
- 资助金额:
$ 16.91万 - 项目类别:
CELL--ECM INTERACTIONS IN MYOCARDIAL FORM AND FUNCTION
心肌形态和功能中的细胞-ECM 相互作用
- 批准号:
3362275 - 财政年份:1989
- 资助金额:
$ 16.91万 - 项目类别:
CELL--ECM INTERACTIONS IN MYOCARDIAL FORM AND FUNCTION
心肌形态和功能中的细胞-ECM 相互作用
- 批准号:
3362272 - 财政年份:1989
- 资助金额:
$ 16.91万 - 项目类别:
相似海外基金
A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease
治疗阿尔茨海默病的人源化单克隆 FSH 阻断抗体
- 批准号:
10279706 - 财政年份:2021
- 资助金额:
$ 16.91万 - 项目类别:
A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease
治疗阿尔茨海默病的人源化单克隆 FSH 阻断抗体
- 批准号:
10693288 - 财政年份:2021
- 资助金额:
$ 16.91万 - 项目类别:
Study of suppressing effect by PAD4 catalytic cleft blocking antibody to rheumatoid arthritis and interstitial pneumonitis
PAD4催化裂隙阻断抗体对类风湿性关节炎和间质性肺炎抑制作用的研究
- 批准号:
17K09982 - 财政年份:2017
- 资助金额:
$ 16.91万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Characterization of a GPCR-blocking antibody for the treatment of breast cancer.
用于治疗乳腺癌的 GPCR 阻断抗体的表征。
- 批准号:
8199615 - 财政年份:2011
- 资助金额:
$ 16.91万 - 项目类别:
Regulation of the IL-31 function by the blocking antibody to IL-31 receptor
IL-31 受体阻断抗体对 IL-31 功能的调节
- 批准号:
22591230 - 财政年份:2010
- 资助金额:
$ 16.91万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The detection of blocking antibody against plasma thrombopoietin in subjects with childhood idiopathic thrombocytopenic purpura
儿童特发性血小板减少性紫癜患者血浆血小板生成素阻断抗体的检测
- 批准号:
13670842 - 财政年份:2001
- 资助金额:
$ 16.91万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




